University of Illinois, Urbana-Champaign

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bausch Makes $50m Commitment For Risute

Novartis AG said when it disclosed that preclinical safety data for Zolgensma were manipulated in the biologic license application for the gene therapy that the company would be "exiting" employees i

Revolution Medicines Inc. 700 Saginaw Drive Redwood City, CA 94063 Web Site: www.revolutionmedicines.com Contact: Martin D. Burke, MD, PhD, Founder Industry Segment: Biotechnology Business:

Financings During the first quarter of 2015, start-up companies raised a total of $2.74 billion, the third quarter in a row in which the record has been broken. (Last quarter’s total was $1.46 billion